Lisata Therapeutics Q3 2025 Earnings NarrowerthanExpected Loss as Biotech Advances Clinical Pipeline Evotec Q1 2026 Earnings EPS Falls Sharply Short of Estimates Amid Operational Pressures YORW Q1 2026 Earnings EPS Beats Estimates as Regulated Utility Shows Steady Performance ALBT Q1 2026 Earnings Narrowed Losses Maintain Focus on Cell Therapy Pipeline GPCR Q1 2026 Earnings NarrowerthanExpected Loss as Pipeline Progress Continues CBOE Q1 2026 Earnings EPS Surge Drives Shares Higher